Cingulate Inc.
CING- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001862150
No open-market purchases or sales by Cingulate Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $9.88M in total; no superinvestor holds it.
Other share classesCINGW
Q2 2024 vs. Q1 2024
How the institutions holding Cingulate Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 9 | 10 | +1 |
| Shares | 117.9K | 680.9K | +563.0K (+477.7%) |
| Value | $128.9K | $217.1K | +$88.3K (+68.5%) |
New holders (4)
Institutions that held Cingulate Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 490,000 | $156.8K | 0.00% |
| Commonwealth Equity Services, LLC | 110,289 | $35.0K | 0.00% |
| Geode Capital Management, LLC | 30,279 | $9.69K | 0.00% |
| Virtu Financial LLC | 20,170 | $6.00K | 0.00% |
Sold out (3)
Institutions that held Cingulate Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Cowen and Company, LLC | 95,000 | $104.5K |
| HRT Financial LP | 10,689 | $11.0K |
| Wells Fargo & Company | 21 | $23 |